Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (116)
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
48,211
Price
$2.42
Total Value
$116.67K
Shares Held After
2,790,103
% of Holdings
1.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
43,367
Price
$2.43
Total Value
$105.38K
Shares Held After
2,741,892
% of Holdings
1.6%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
1,700
Price
$2.70
Total Value
$4.59K
Shares Held After
385,075
% of Holdings
0.4%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.04
Total Value
$15.20K
Shares Held After
635,812
% of Holdings
0.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.94
Total Value
$940.00
Shares Held After
369,485
% of Holdings
0.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
229
Price
$73.95
Total Value
$16.93K
Shares Held After
492,241
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
7
Price
$2.48
Total Value
$17.36
Shares Held After
2,698,525
% of Holdings
0.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
10,053
Price
$2.79
Total Value
$28.05K
Shares Held After
383,375
% of Holdings
2.6%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.74
Total Value
$261.00K
Shares Held After
300,000
% of Holdings
50.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
25,000
Price
$1.96
Total Value
$48.90K
Shares Held After
461,904
% of Holdings
5.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.90
Total Value
$900.00
Shares Held After
368,485
% of Holdings
0.3%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$1.99
Total Value
$39.80K
Shares Held After
436,904
% of Holdings
4.6%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,500
Price
$0.97
Total Value
$5.33K
Shares Held After
367,485
% of Holdings
1.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
300
Price
$73.69
Total Value
$22.11K
Shares Held After
492,012
% of Holdings
0.1%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
14,338
Price
$2.46
Total Value
$35.27K
Shares Held After
2,698,518
% of Holdings
0.5%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,400
Price
$0.96
Total Value
$5.21K
Shares Held After
361,985
% of Holdings
1.5%
Serina Therapeutics, Inc. (SER)
Brannan Stephen K. — Director
Shares
1,000
Price
$2.03
Total Value
$2.03K
Shares Held After
1,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
15,810
Price
$2.48
Total Value
$39.21K
Shares Held After
2,684,180
% of Holdings
0.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
30,000
Price
$2.03
Total Value
$61.04K
Shares Held After
416,904
% of Holdings
7.2%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.59
Total Value
$238.50K
Shares Held After
150,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
27,062
Price
$2.49
Total Value
$67.38K
Shares Held After
2,668,370
% of Holdings
1.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$2.05
Total Value
$41.04K
Shares Held After
386,904
% of Holdings
5.2%
Larimar Therapeutics, Inc. (LRMR)
Hamilton Thomas Edward — Director
Shares
50,000
Price
$3.34
Total Value
$166.89K
Shares Held After
714,798
% of Holdings
7.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
10,000
Price
$1.98
Total Value
$19.80K
Shares Held After
366,904
% of Holdings
2.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,821
Price
$2.49
Total Value
$24.45K
Shares Held After
2,641,308
% of Holdings
0.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
147
Price
$1.55
Total Value
$227.85
Shares Held After
73,135
% of Holdings
0.2%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,460
Price
$1.55
Total Value
$2.26K
Shares Held After
724,395
% of Holdings
0.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,400
Price
$71.97
Total Value
$100.76K
Shares Held After
491,712
% of Holdings
0.3%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$1.98
Total Value
$39.60K
Shares Held After
356,904
% of Holdings
5.6%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,736
Price
$19.05
Total Value
$33.07K
Shares Held After
80,737
% of Holdings
2.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
71,612
Price
$2.49
Total Value
$178.31K
Shares Held After
2,631,487
% of Holdings
2.7%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
398
Price
$1.55
Total Value
$616.90
Shares Held After
72,988
% of Holdings
0.5%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
3,946
Price
$1.55
Total Value
$6.12K
Shares Held After
722,935
% of Holdings
0.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
312
Price
$71.99
Total Value
$22.46K
Shares Held After
490,312
% of Holdings
0.1%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
240,000
Price
$0.04
Total Value
$10.34K
Shares Held After
94,124,319
% of Holdings
0.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
600
Price
$24.22
Total Value
$14.53K
Shares Held After
46,688
% of Holdings
1.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,400
Price
$23.40
Total Value
$102.96K
Shares Held After
46,088
% of Holdings
9.5%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
3,057
Price
$1.93
Total Value
$5.90K
Shares Held After
15,492
% of Holdings
19.7%
Absci Corp (ABSI)
Szela Mary T — Director
Shares
12,900
Price
$11.54
Total Value
$148.87K
Shares Held After
21,300
% of Holdings
60.6%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
100
Price
$2.50
Total Value
$250.00
Shares Held After
2,559,875
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
25,930
Price
$2.54
Total Value
$65.86K
Shares Held After
2,559,775
% of Holdings
1.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
55
Price
$1.54
Total Value
$84.70
Shares Held After
72,590
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
545
Price
$1.54
Total Value
$839.30
Shares Held After
718,989
% of Holdings
0.1%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,255
Price
$24.98
Total Value
$106.29K
Shares Held After
41,688
% of Holdings
10.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,638
Price
$23.88
Total Value
$39.12K
Shares Held After
37,433
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,910
Price
$22.95
Total Value
$43.83K
Shares Held After
35,795
% of Holdings
5.3%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,436
Price
$1.93
Total Value
$4.70K
Shares Held After
14,394
% of Holdings
16.9%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,531
Price
$1.93
Total Value
$4.88K
Shares Held After
21,729
% of Holdings
11.6%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
2,106
Price
$1.93
Total Value
$4.06K
Shares Held After
13,113
% of Holdings
16.1%
Showing 1–50 of 116 transactions (page 1 of 3)